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Abstract 
-synuclein (-syn) is a 140-residue intrinsically disordered protein that is 
involved in neuronal and synaptic vesicle plasticity but its aggregation to form 
amyloid fibrils is the hallmark of Parkinson’s disease (PD). The interaction 
between -syn and lipid surfaces is believed to be a key feature for mediation of 
its normal function but under other circumstances is able to modulate amyloid 
fibril formation. Using a combination of experimental and theoretical 
approaches, we have identified in this study the mechanism through which facile 
aggregation of -syn is induced under conditions where it binds to a lipid 
bilayer, and we show that the rate of primary nucleation can be enhanced by 
three orders of magnitude or more under such conditions. These results reveal 
the key role that membrane interactions can play in triggering conversion of -
syn from its soluble state into the aggregated state that is associated with 
neurodegeneration and to its associated disease states. 
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Introduction 
Substantial evidence links -synuclein (-syn), a small (14 kDa) highly conserved 
pre-synaptic protein, to both familial and sporadic types of Parkinson’s disease 1-7. 
When isolated in solution, -syn is intrinsically disordered but in the presence of lipid 
surfaces the protein adopts a highly helical structure 
8-14
 that is believed to mediate its 
normal functions, including control of synaptic membrane processes and biogenesis, 
regulation of neurotransmitter release and synaptic plasticity, and modulation of 
neuronal survival 
2,6,15-19
. The interaction between -syn and lipids has also been 
shown to modulate amyloid fibril formation in different ways depending on the 
relative proportion of the two species 
20-25
. Recent studies have suggested that -syn 
may co-aggregate with lipid molecules upon amyloid formation, and that the 
lipid:protein ratio can affect the morphology of the amyloid fibrils 
26
, indicating the 
importance of achieving a global understanding of the effect of lipids on the kinetics 
of amyloid formation by -syn. 
In the study reported here, we identify by means of a combination of experimental 
and theoretical approaches a mechanism through which small unilamellar vesicles 
(SUVs) prepared from the phospholipid 1,2-dimyristoyl-sn-glycero-3-phospho-L-
serine (DMPS) perturb the kinetics of -syn amyloid formation 27-29. Our findings 
indicate that the presence of SUVs can enhance the rate of the essential primary 
nucleation step that initiates amyloid formation by three orders of magnitude or more, 
providing a global explanation of the dramatic modulation of the kinetics of -syn 
amyloid formation by lipid vesicles 
20,22,24,25
. By contrast, under these conditions other 
microscopic processes, including homogeneous primary nucleation in bulk solution, 
secondary nucleation and fragmentation, do not contribute significantly to the 
aggregation reaction. These results provide a mechanistic description of the key role 
that specific membrane interactions can play in triggering conversion of -syn from 
its soluble state into the aggregated state that is associated with neurodegenerative 
disease. 
Results 
The kinetics of -syn aggregation are modulated by SUVs 
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In this study, we chose to work with a physiologically relevant lipid, 
phosphatidylserine (PS), which, together with phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE), is one of the most abundant components of the 
membranes of synaptic vesicles 
30
. In order to probe the influence of lipid vesicles on 
the aggregation behaviour of -syn, we first investigated the interaction between the 
protein and SUVs prepared from DMPS, using circular dichroism (CD) spectroscopy 
(Fig. 1a and Supplementary Results, Supplementary Fig. 1a). We monitored the 
change in the mean residue ellipticity of -syn (25 M (blue data) and 50 M (black 
data)) for increasing DMPS:-syn ratios, and the data are consistent with a single-step 
mode of binding (Fig. 1a) with a dissociation constant, KD, of 3.8  1.3  10
-7
 M and a 
stoichiometry, L, of 28.2  0.8, where L is the total number of DMPS molecules in 
the bilayer that are involved in binding one molecule of -syn. Interestingly, the size 
of the vesicles in the range of 20 - 100 nm does not detectably affect the affinity of 
the protein for the vesicles (See Supplementary Fig.1b). It is also interesting to note 
that if we assume that the lipid-bound protein molecules occupy a shell of 5 nm 
thickness on the external surfaces of the SUVs, by taking the hydrodynamic radius of 
the protein to be 26 Å 
31
 we can convert this stoichiometry into a local effective 
concentration of ca. 36 mM (See Methods for details), nearly 10
3
 times higher than 
that in bulk solution. We then monitored the kinetics of aggregation of -syn in the 
presence of these SUVs at 30C under quiescent conditions, using different DMPS:-
syn ratios (Fig. 1b-d). 
In the absence of SUVs under these conditions, no increase in the fluorescence signal 
of ThT was observed over more than 65 hours, indicating the absence of detectable 
amyloid formation 
22
. Similarly, no increases in ThT fluorescence were detected when 
-syn (50 M) was incubated in the presence of an excess of DMPS SUVs (DMPS:-
syn  40), i.e. when the only state of the protein that is significantly populated is that 
bound to the SUVs (Fig. 1a); this finding is consistent with, and indeed rationalises, 
previous conclusions that the presence of lipid vesicles can inhibit amyloid formation 
by -syn 24,25,32. In addition, however, when short pre-formed fibrils (20 M) were 
incubated with an excess of DMPS SUVs (2, 4 and 8 mM, DMPS:-syn  100), the 
protein was found to dissociate from the fibrils (Fig. 2a) and to populate the lipid-
bound monomeric -helical state (Fig. 2b) (See Methods for details). This transition 
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is most likely to occur via the dissociation from the fibrils of monomeric -syn, 
which, once free in solution, can bind to the SUVs; indeed the slow time scale of the 
equilibration, ca. 3 hours (Fig. 2a), is consistent with this mechanism (See Methods 
for details). This observation, together with the KD value measured for the interaction 
between -syn and SUVs, indicates that the lipid-bound -helical state of -syn is 
thermodynamically more stable than the fibrillar state under these conditions. 
Therefore, the absence of amyloid formation in the presence of high concentrations of 
SUVs, as well as the dissolution of pre-formed fibrils, can easily be rationalised as 
two manifestations of the high thermodynamic stability of the lipid-bound state. 
By contrast, when -syn (50 M) was incubated at lower concentrations of DMPS 
(DMPS:-syn ratios between 2 and 15), i.e., when there were significant populations 
of monomer both free in solution and bound to the vesicles, rapid formation of 
amyloid fibrils was observed independently of the average size of the vesicles (See 
Supplementary Fig 2), the quantities of which increased steadily as the concentration 
of DMPS was increased (Fig. 1b). In addition, as the DMPS:-syn ratio was 
increased, the rate of amyloid formation decreased (Fig. 1b-d), a finding that can be 
attributed to the depletion of free monomeric -syn in solution by the presence of 
DMPS SUVs; a similar phenomenon has been observed for the A-peptide, the 
aggregation of which is associated with Alzheimer’s disease, in the presence of 
polymeric nanoparticles 
33
. This observed decrease of the rate of amyloid formation 
for high DMPS:-syn ratios is also likely to be attributable in part to an increasing 
average distance between the molecules of -syn bound to the SUVs, thus reducing 
its local concentration. Taken together, these results show that the maximum rate of 
amyloid formation by syn in the presence of DMPS SUVs is observed for 
DMPS:-syn ratios of 8; below this value, the rate of amyloid formation is limited by 
the concentration of bound -syn, whereas above this value the rate of aggregation is 
limited by the concentration of free monomeric protein. 
We compared the binding of -syn to DMPS SUVs in the absence and presence of 
added salt (sodium chloride, NaCl, at concentrations of 25 and 50 mM). The affinity 
of -syn for the DMPS SUVs was observed to decrease as the concentration of NaCl 
increased, (Fig. 3a) as illustrated by the increase in both the stoichiometry (from ca. 
28 (no salt) to ca. 60 (50 mM NaCl)) and the dissociation constant (from 0.38 (no 
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salt) to 11 M (50 mM NaCl)) upon addition of NaCl; this observation is attributable 
to the screening of the electrostatic interactions between the negatively charged lipid 
polar heads of the SUVs and the positively charged N-terminal region of -syn. We 
then monitored the formation of amyloid fibrils in the absence and the presence of 25 
and of 50 mM NaCl (Fig. 3b) and observed that the kinetics of amyloid formation 
slowed down as the concentration of NaCl increased, suggesting that the interaction 
between -syn and the DMPS SUVs is necessary to stimulate -syn aggregation. 
Overall, these results reveal that the presence of SUVs very strongly enhances the rate 
of amyloid formation by -syn under the conditions used here where the DMPS:-
syn ratio is lower than 40 (Fig. 1c), i.e. when there is free as well as bound -syn 
present in solution as we discuss further below. 
syn and SUVs play distinct roles in amyloid formation 
The experimental data show, therefore, that there is a dynamical equilibrium between 
the protein free in solution and bound to vesicles. In order to understand the 
contribution of these two populations (free and bound -syn) to the kinetics of 
amyloid formation, we monitored the formation of amyloid fibrils under conditions 
where the concentrations of -syn free in solution (Fig. 4a) and bound to the vesicles 
(Fig. 4b) were systematically varied in turn by changing the total concentrations of 
both protein and DMPS SUVs (Eqs. 6-8 in Methods). The concentration of protein 
molecules converted into fibrils, determined by absorbance analysis (Eqs. 9 and 10 in 
Methods), was found to be constant, at ca.15 M, when the concentration of DMPS 
was 300 M, for all the different initial concentrations of -syn free in solution (Fig. 
4c); it was, however, found to be proportional to the initial concentration of -syn 
bound to the vesicles, with a constant of proportionality of approximately two (Fig. 
4d). Interestingly, if secondary processes such as fibril fragmentation or autocatalytic 
nucleation 
27
 were to contribute to the formation of new fibrils, the total concentration 
of protein converted into fibrils would be expected to approach the initial 
concentration of free monomeric protein (see Fig. 4c,d). Our results reveal, however, 
that under the conditions used here, the concentration of protein converted into fibrils 
when the aggregation kinetics had reached the plateau phase (Fig. 4a,b) did not 
depend on the initial concentration of free -syn but rather on that of DMPS (Fig. 
4c,d). 
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In order to probe whether or not the nucleation and growth of amyloid fibrils on the 
lipid vesicles influences the structure of the SUVs, we used membrane fluidity as 
observable by monitoring changes in fluorescence polarisation (FP) of 1,6-diphenyl-
hexa-1,3,5-triene (DPH) 
34
. Interestingly, the binding of monomeric -syn to the 
DMPS membrane decreased its melting temperature from 41C to 30C 
(Supplementary Fig. 3a); a similar finding has been reported for DPPC membranes 
35
. 
In addition, the fluorescence polarisation of DPH when embedded within the 
membrane bilayers was observed to be enhanced as amyloid formation proceeded 
(Supplementary Fig. 3b), suggesting that the bilayer becomes even more rigid 
34
 and 
that the formation of amyloid fibrils does not disrupt the lipid vesicles. 
Analysis using atomic force microscopy (AFM) indicated that two distinct types of 
structures were present in the plateau region of ThT fluorescence (Fig. 5a,b), both of 
which differ from those observed in the absence of SUVs (Fig. 5c) 
36
. Some structures 
appear as small spherical species with a diameter of < 50 nm, and can be attributed to 
SUVs coated with -syn molecules, and other species can be identified as thin (< 5 
nm in height) filaments that appear to be attached to the SUVs, and we attribute these 
species to amyloid fibrils whose formation had been nucleated on the surface of the 
SUVs. The average length of the fibrils observed by AFM is ca. 375 nm, a value 
indicating that on average only a single nucleation event had occurred at each vesicle 
(see Methods for details). This observation, along with the images from the AFM 
analysis, shows that only a small fraction of all bound -syn molecules contributes to 
the formation of an active nucleus from which a fibril can grow. 
These experiments also indicate that a large proportion of monomeric protein 
molecules remained in solution when no further change in the ThT fluorescence 
intensity was observed (Fig. 4c), showing that amyloid formation induced by the 
presence of SUVs had slowed down and effectively ceased by mechanisms other than 
that of the simple depletion of free monomer that is generally observed during studies 
of amyloid formation in homogeneous solution 
37
. Indeed, we isolated the remaining 
free monomer at the end of the first amyloid formation reaction (See Methods for 
details) and incubated the latter with a fresh solution of DMPS SUVs (Fig. 5d); this 
incubation resulted in a second batch of fibrils with morphologies very similar to 
those of the species formed in the initial reaction (Fig. 5d). Furthermore, sonication of 
the reaction mixture resulted in the breakage of fibrils into small fragments (Fig. 5e) 
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that with further incubation grew into much larger fibrils with a morphology very 
similar to that of fibrils formed in the absence of lipid vesicles in an agitated solution 
(Fig. 5e) 
36
. These findings suggest that the end state of the aggregating solution, i.e. 
when the plateau in fluorescence intensity is reached, represents a kinetically trapped 
state due to the quiescent conditions used in these experiments. Under other 
conditions the fibrils would be able to proliferate as a result of secondary processes 
such as fragmentation as we show using sonication techniques. These conditions thus 
allow us to probe in detail the primary nucleation process that is otherwise difficult to 
study because, in the presence of secondary processes, the latter usually dominate the 
kinetics of the aggregation reaction 
38
. 
Taken together, therefore, these observations show that the rates of secondary 
nucleation and fragmentation are negligible under the quiescent conditions of our 
experiments, and that amyloid formation ceases either because of the depletion of 
nucleation sites on the SUVs and/or because of the inactivation of growing fibril ends, 
and not because of the depletion of free -syn. These results therefore indicate that 
the effect of the SUVs is to enhance dramatically the rate of primary nucleation of -
syn self-assembly. 
Vesicles can enhance the nucleation rate by a thousand-fold 
Analysis of the kinetics of amyloid formation under carefully chosen and controlled 
conditions has been shown to enable the determination of the key microscopic steps in 
the mechanism of protein aggregation as well as their associated molecular rate 
constants 
27-29,39-42
. Substantial evidence points towards the fact that heterogeneous 
primary nucleation, i.e. nucleation taking place at an interface, for example air/water 
or lipid/water, rather than homogeneous primary nucleation involving only free 
monomers in bulk solution, is the initial step in -syn aggregation 43-45. We 
considered two possible mechanisms to describe the heterogeneous primary 
nucleation process accelerated by the presence of SUVs. The first and simplest is a 
”one-step nucleation” model, directly converting monomers into nuclei 46 (Eqs. 11-13 
in Methods). In addition, we considered a more complex mechanism involving a 
conversion step in the nucleation process; indeed, a conversion step has been found 
from single molecule experiments 
47
 to occur during the formation of -syn 
aggregates in bulk solution under shear conditions, where initially formed 
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disorganised oligomers were found to convert into more highly structured species. In 
this ”two-step nucleation” model, a pre-nucleus, (indicated as A in the kinetic 
equations in the Methods) is formed and then rearranges, with a rate constant kb, to 
form a growth competent nucleus, P (Eqs. 11 and 14-17 in Methods). In the analysis, 
we have focused on the early times of the aggregation reaction where the influence of 
primary nucleation is most marked. Moreover, in this regime, the concentration of 
monomeric protein remains constant to a good approximation, a factor that allows an 
analytical treatment of the rate equations 
39,48
. Using this approach, we found that both 
models of nucleation can describe well the early time regions of the complete set of 
experimental curves (Fig. 6a,b and Supplementary Fig. 4) where our analysis is 
applicable (see Methods), confirming that a greatly enhanced primary nucleation rate 
is the origin of the much more rapid formation of amyloid fibrils in the presence of 
SUVs. 
Global analysis of the kinetic data, in which all the aggregation time courses in a 
series of experiments are fitted with a single set of parameters, also indicates that the 
apparent reaction order of the nucleation step relative to free monomeric protein is ca. 
0.2, i.e. it is close to 0, whilst homogeneous primary nucleation rates in bulk solution 
typically have reaction orders greater than 1.0 
37
. This observation reveals that the 
formation of -syn nuclei in the presence of vesicles does not depend significantly on 
the concentration of free monomer, and therefore that free monomers are not directly 
involved in the rate-determining step of the nucleation process. 
This analysis shows in addition that the rate of fibril elongation from the vesicles 
saturates at monomer concentrations higher than ca. 100 M, a value close to that 
observed for the saturation of the elongation of pre-formed fibrils in the absence of 
SUVs 
36
. If we make the assumption that the elongation rate constant is similar in the 
presence of SUVs to that in their absence, the latter having been determined to be ca. 
2 • 103 M-1 s-1 36, the rate of formation of new nuclei by -syn at the membrane 
interface can be estimated from our analysis to be ca. 1 • 10-14 M s-1 at a DMPS 
concentration of 300 M. This value is, remarkable, more than three orders of 
magnitude greater than the upper limit of the nucleation rate estimated for quiescent 
conditions in the absence of SUVs (7 • 10-18 M s-1, see Methods for details). 
Interestingly, an analysis using the ”two-step nucleation” model requires a rate of 
conversion between the two types of nuclei of ca. 2 • 10-5 s-1. This rate is very close to 
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the rate of conversion between the two distinct types of oligomers observed in single 
molecule experiments, 5 • 10-6 s-1, in the absence of SUVs 47, suggesting that this two-
step model could well apply to the type of heterogeneous nucleation in the presence 
of SUVs that has been identified in the present work (see residuals of the fits using 
the two models in Supplementary Fig. 5). 
Discussion 
The results described in this paper provide a self-consistent explanation for the 
observed modulation of -syn amyloid formation by lipid vesicles 20,22. At high 
lipid:-syn ratios, essentially all of the protein molecules are bound to the surface of 
the vesicles, in predominantly helical conformations 
10
, and, in the absence of free 
monomeric -syn, aggregation does not take place at a detectable rate. At low lipid:-
syn ratios, however, when free monomer is present in solution, primary nucleation 
occurs on the vesicle surfaces on which -syn is bound. The rate of this nucleation 
reaction is at least three orders of magnitude greater than that occurring in bulk 
solution, a result that can be attributed to the high local concentration of protein 
molecules at the surface of the vesicle and to their likely ability to explore 
conformations that may favour primary nucleation but are rare in solution 
10
. It is 
important to note in this context that the magnitude by which the rate of primary 
nucleation rate is increased by lipid vesicles is likely to be affected by their 
composition. 
Interestingly, it has recently been shown that the numbers of vesicles and of -syn 
molecules in a functional synaptosome, or synaptic button, are ca. 400 and ca. 3000, 
respectively, which correspond to an -syn:vesicle ratio of ca. 10:1 49. In our study, 
we have shown that lipid vesicles enhance amyloid fibril formation when the 
DMPS:-syn is below 40, corresponding to a -syn:vesicle ratio of 100:1, a value one 
order of magnitude greater than that observed in vivo. Given the difference between 
the composition of DMPS SUVs and synaptic vesicles, however, it is noteworthy that 
these ratios are similar to within an order of magnitude. In addition, the fact that we 
have observed a closely similar enhancement of the primary nucleation rate of -syn 
in the presence of both small (SUVs, < 20nm diameter) and large DMPS (LUVs, > 
100nm diameter) vesicles suggests that membrane curvature does not play a very 
significant role for either the binding or the nucleation of -syn, at least under the 
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conditions used in our study, presumably because even the smallest vesicles are not 
significantly curved on the scale of a protein monomer, enabling us to state that our 
results are significant in the context of the vesicle sizes found in vivo, e.g. the 
secretory vesicles for neurotransmitters have a diameter of ca. 40 nm 
49
. 
The fact that the stimulation of amyloid formation via the enhancement of primary 
nucleation, the vital first step in any spontaneous aggregation process, occurs only 
above a threshold value of the -syn:lipid ratio is of particular interest in the light of 
evidence that over-expression of -syn via gene duplication or triplication, both of 
which are likely to lead to an increase in the -syn:synaptic vesicle ratio in vivo, 
results in early onset forms of Parkinson’s disease 19. Such changes reflect the fact 
that the transition between functional interactions of -syn with lipid membranes and 
deleterious ones that can generate pathogenicity is likely to be finely balanced, such 
that relatively small changes in concentration can cause dramatic increases in the risk 
of pathogenic behaviour 
50
. The present findings, therefore, contribute to our 
understanding of how the aggregation of -syn in vivo can lead not only to a lack of 
functional protein molecules but also to species toxic to neuronal cells in vivo 
2
. More 
generally, the discovery of the dramatic increase that can occur in the rate of the 
primary nucleation of -syn in the presence of specific membrane surfaces provides a 
possible explanation of the way that the key initial steps in the process of aggregation 
of -syn could occur in a cellular environment and ultimately lead to the onset and 
proliferation of disease. 
  
 11 
Acknowledgements: We wish to thank Myriam Ouberai for her help with the 
preparation of SUVs and herself, Christopher Waudby and John Christodoulou for 
valuable discussions. This work was supported by the UK BBSRC (BB/H003843/1, 
CMD, MV) and the Wellcome Trust (094425/Z/10/Z, CMD, TPJK, MV), the 
European Research Council (337969, TPJK) the Frances and Augustus Newman 
Foundation (TPJK), Magdalene College, Cambridge (AKB), St John’s College, 
Cambridge (TCTM), the Cambridge Home and EU Scholarship Scheme (GM), Elan 
Pharmaceuticals (CMD, TPJK, MV, CG, AKB) and the Leverhulme Trust (AKB). 
Competing Interests: The authors declare they have no competing interests as 
defined by Nature Publishing Group, or other interests that might be perceived to 
influence the results and discussion reported in this paper. 
Correspondence: Correspondence and requests for materials should be addressed to 
C.M.D. (email: cmd44@cam.ac.uk). 
Authors contributions: CG performed the experiments and AKB recorded the AFM 
images. CG, AKB, TPJK, MV and CMD were involved in the design of the study. 
CG, AKB, GM and CMD wrote the paper and all the authors were involved in the 
analysis of the data and editing of the paper. 
  
 12 
Figure 1. Modulation of the kinetics of -synuclein amyloid formation by lipid 
vesicles. (a) Change in the CD signal of -syn (25 M (blue) and 50 M (black)) 
measured at 222 nm as a function of [DMPS]:[-syn] (M:M) ratios. The data (blue 
dots, 25 M) fit well to a single step binding model (Eq. 6, KD = 3.8 ± 1.3 • 10
-7
 M 
and L = 28.2 ± 0.8, blue line). L is the stoichiometry of the reaction and corresponds 
to the average number of lipid molecules bound to each molecule of monomeric -
syn. (b, d) Duplicates of fluorescence measurements monitored as a function of time 
when -syn (50 M) was incubated in the absence (grey) and presence of increasing 
concentrations of DMPS (100 (purple), 200 (dark blue), 300 (blue), 400 (cyan), 500 
(green), 750 (light green), 1000 (yellow), 1500 (orange), 2000 (red) M). (c) 
Variation in the maximum rate of aggregation of -syn with changes in the DMPS:-
syn ratio. For DMPS:-syn ratios above 40, no stimulation of amyloid formation is 
observed because effectively all the -syn monomers required for the growth of the 
aggregates are bound to the surfaces of the vesicles. The data correspond to mean 
values ± s.d. 
Figure 2. Dissolution of -syn fibrils in the presence of an excess of DMPS SUVs. 
(a) Change in the ThT fluorescence with time when 20 M pre-formed amyloid fibrils 
were incubated in the presence of an excess of DMPS SUVs at 37ºC (2 mM (grey), 4 
mM (blue) and 8 mM (green)). (b) Change in the CD signal of -syn when 20 M 
pre-formed amyloid fibrils were incubated in the presence of 2 mM DMPS SUVs at 
37ºC (t = 0 (grey), 5 (purple), 17 (dark blue), 39 (blue), 81 (green), 165 (light green), 
205 (yellow), 275 min (orange)). Insert: change in the CD signal of -syn measured at 
222 nm as a function of time.  
Figure 3. Effect of the presence of salts on the binding of syn to DMPS SUVs 
and on its kinetics of amyloid formation. (a) Change in the CD signal measured at 
222 nm of 50 M of -syn monitored in the presence of increasing concentrations of 
DMPS SUVs in the absence (grey) and the presence of 25 (blue) and 50 mM NaCl 
(green) at 30ºC. (b) Change in the ThT fluorescence when 50 M -syn is incubated 
in the presence of 100 M DMPS in the absence (grey) and presence of 25 (blue) and 
50 mM NaCl (green) at 30ºC). 
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Figure 4. Effect of the variation of the concentration of DMPS SUVs and free 
monomeric -syn on the kinetics of -syn amyloid formation. (a,b) Duplicates of 
the change in the fluorescence signal of ThT when increasing concentrations of -syn 
(60 (black), 80 (blue), 100 (light blue), 125 (dark green), 175 (green), 200 M 
(yellow)) were incubated in the presence of a constant concentration of DMPS (300 
M) (a), and when free monomeric -syn (140 M) was incubated in the presence of 
increasing concentrations of DMPS (60 (black), 120 (purple), 180 (dark blue), 240 
(light blue), 300 (dark green), 450 (light green), 600 (yellow), 1200 (orange) M) (b). 
(c,d) Change in the concentration of -syn that is converted into fibrils as a function 
of the concentration of -syn free in solution (c), or bound to the SUVs (d). The red 
lines correspond to the change in the concentration of -syn that would be converted 
into fibrils as a function of the concentration of -syn free in solution (c), or bound to 
the SUVs (d), if secondary processes were to dominate the kinetics of -syn amyloid 
formation ([-synfibrils]=[-syntotal]initial). 
Figure 5. Differences in the morphology of -syn aggregates formed in the 
presence and absence of DMPS SUVs. (a,b) AFM images of aggregates of -syn 
formed after incubation of 200 M monomeric -syn in the presence of 600 M 
DMPS SUVs ((b) Expanded region of the image in (a)) and (c) in the presence of pre-
formed seed fibrils 
36
. (d, e) Changes in the ThT fluorescence signal observed (d) 
when the solution of the remaining free monomers is incubated in the presence of 
fresh DMPS SUVs (300 M), and (e) after sonication of the reaction mixture for 10s 
at the end of the process of amyloid formation. The concentrations of -syn converted 
into fibrils were found to be 20 (d) and 50 M (e), respectively. The scale bars of the 
AFM images correspond to 1 m (a,e), 500 nm (b,d) and 4 m (c). 
Figure 6. Global kinetic analysis of -syn aggregation data with a two-step 
nucleation model. (a,b) Global fits of the early time-points of the -syn aggregation 
curves obtained for the different monomer and DMPS concentrations using a two-step 
nucleation mechanism (see Methods for details) (Eq. 16, knk+ = 1.2 • 10
-5
 M
-(n+1)
 s
-2
, 
KM = 125 M , n = 0.2, kb = 1.9 • 10
-5
 s
-1
) (see Fig. 4a,b for the complete time 
curves). The scheme summarises the proposed mechanism of amyloid formation by 
-syn in the presence of DMPS SUVs based on the experimental evidence described 
in this paper.  
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Online methods 
Reagents 
1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (sodium salt) (DMPS) was purchased 
from Avanti Polar Lipids, Inc. Sodium phosphate monobasic (NaH2PO4, 
BioPerformance Certified,  99.0%), sodium phosphate dibasic (Na2HPO4, 
ReagentPlus
®
,  99.0%), sodium chloride (NaCl, BioXtra  99.5%), 1,6-diphenyl-
hexa-1,3,5-triene (DPH, 98%), ethanol (EtOH,  99.8%) and Triton X-100 were 
purchased from Sigma Aldrich. Thioflavin T UltraPure Grade (ThT,  95%) was 
purchased from EUROGENTEC LTD. 
Protein and lipid preparation 
Wild type -syn was expressed and purified as previously described 36,51. The lipids 
were dissolved in 20 mM phosphate buffer (NaH2PO4/NaH2PO4), pH 6.5, and stirred 
at 45ºC for two hours. The solution was then frozen and thawed 5 times using dry ice 
and a water bath at 45ºC, respectively. The preparation of small or large unilamellar 
vesicles, SUVs or LUVs, respectively, was done using sonication (3  5 min, 50 % 
cycles, 10 % maximum power) on ice or extrusion through 100 nm pore diameter 
membranes (Avanti Polar Lipids, Inc) at 45ºC, respectively. After centrifugation, the 
sizes of the SUVs and LUVs were checked using dynamic light scattering (Zetasizer 
Nano ZSP, Malvern Instruments, Malvern, UK) and show to consist of a distribution 
centred at 20 and 100 nm diameter, respectively. 
CD spectroscopy 
Sample preparation and data acquisition 
CD samples were prepared by incubating 50 M -syn in the presence of increasing 
concentrations of DMPS SUVs in 20 mM phosphate buffer, pH 6.5. Far-UV CD 
spectra were recorded on a JASCO J-810 equipped with a Peltier thermally controlled 
cuvette holder at 30ºC. Quartz cuvettes with path lengths of 1 mm were used and CD 
spectra were obtained by averaging five individual spectra recorded between 250 and 
200 nm with a bandwith of 1 nm, a data pitch of 0.2 nm, a scanning speed of 50 
nm/min, and a response time of 1 s. Each value of the CD signal intensity reported at 
222 nm corresponds to the average of five measurements, each acquired for 10 s. For 
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each protein sample, the CD signal of the buffer used to solubilise the protein was 
recorded and subtracted from the CD signal of the protein. 
Data analysis 
The CD signal shown in this paper (     ) can be described as follow: 
                  (1) 
where    and    are the fractions of -syn bound to the membrane and free in 
solution, respectively, and     and     are the CD signals of the bound and free 
form of -syn, respectively. By assuming that        , and that the signals of -
syn in the presence of buffer, or in the presence of SUVs under saturating conditions, 
correspond to     and    , respectively, the fraction of -syn bound to the SUVs for 
each sample can be expressed as: 
   
         
       
 (2) 
We use the following model:                 and the corresponding 
equations (Eq. 2 and 6) to fit the data, where F and B are -syn free in solution and 
bound to the vesicles, respectively, and L is the number of DMPS molecules 
interacting with one molecule of -syn. 
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Using the values of KD (in M), as well as the stoichiometry, L, obtained from the fit, 
we estimated the concentration of the protein bound to the vesicles (b) and of the 
protein free in solution (m) and for any given DMPS:-syn ratio: 
    [     ] (7) 
  [     ]    (8) 
Estimation of the local concentration of -syn at the surface of a SUV 
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We estimated the local concentration of -syn at the surface of each SUV by 
assuming that all the protein molecules bound to the lipid surface occupy a shell of 5 
nm thickness at the outside of the SUVs, based on the hydrodynamic radius of 
monomeric -syn in solution of 2.5 nm 31. This layer has a volume of 1.4  10-24 m3 
(  
 
 
   
  
 
 
   
 , r1 = 15 nm and r2=10 nm). By assuming that the area per lipid of 
DMPS is of the order of 0.40 nm
2
 
52
, we estimated that ~ 3,140 lipid molecules of 
DMPS are exposed per SUV 
(                                    
              
                        
), therefore there are a 
total number of ~ 6,000 lipid molecules of DMPS per SUV. For a given 
stoichiometry, L, the local concentration of -syn at the surface of each SUV can be 
estimated by [     ]      
    
    
, with NA the Avogadro number and V in dm
3
. 
Analysis of the dissociation of pre-formed -syn amyloid fibrils by high 
concentrations of SUVs 
The combined circular dichroism and ThT experiments shown in Figure 2 suggest 
that, even in the presence of 2 mM SUVs, 20 M of pre-formed short (through 
sonication) fibrils are quantitatively dissociated. We can use the ThT time traces to 
analyse the kinetics of dissociation and check whether or not they are consistent with 
the dissociation of monomers from the ends of the fibrils, which subsequently bind to 
the SUVs. Therefore free monomers are constantly removed and the equilibrium is 
slowly shifted away from the fibrillar state. In principle, one would expect a constant 
rate of decrease of ThT fluorescence, if a homogeneous population of fibrils 
dissociates, as each fibril will dissociate independently of the others. We observe, 
however, that the rate of dissociation decreases over time. This feature presumably 
stems from the fact that the fibrils are not mono-dispersed in length, but rather display 
a distribution of lengths, ranging from less than 50 nm to more than 200 nm in length 
36
. Therefore the short fibrils will vanish first and the total number of dissociating 
fibrils will decrease with time, rationalizing the observed decrease in rate. For our 
analysis, we considered only the initial linear part of the data, where the concentration 
(by number) of fibrils is likely to correspond to the (known) initially added 
concentration. 
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The difference in absolute fluorescence intensity between the data in the presence of 
2, 4 and 8 mM SUVs, as well as the small increase in fluorescence at the beginning of 
the experiments are likely to be due to effects of the lipids on the ThT fluorescence. If 
the curves are normalised such that the maximal values are set to 1.0 in each case, the 
initial rates of dissociation differ by less than a factor of two. We will use the mean of 
the three observed dissociation rates, 3.53 • 10-9 M s-1 for our calculation of the 
molecular rate constant. The concentration by number of dissociating fibrils can be 
calculated from the average number of monomers per fibril (180 
36
) to be ca. 1.1 • 10-7 
M. Therefore we obtain a dissociation rate constant koff of 3.2 • 10
-2
 s
-1
. This value 
can be compared to that of the dissociation rate constant that can be calculated by 
assuming that at thermodynamic equilibrium, the growth and dissociation rates are 
equal. The monomer concentration at equilibrium has been reported to be ca. 1.6 M 
53
. Together with an elongation rate constant of 2.2 • 103 M-1 s-1 36, this value yields a 
dissociation rate constant koff of 3.52 • 10
-3 
s
-1
. The results of these two approaches 
give values that are consistent to within one order of magnitude and indeed the 
apparent difference may be due to the approximations made during the calculations, 
as well as to uncertainties in the reported values of the equilibrium free monomer 
concentration and the elongation rate constant. We conclude that the dissolution of the 
pre-formed fibrils upon the addition of excess concentrations of SUVs is consistent 
with a mechanism in which the SUVs bind most of the free monomeric -syn 
molecules, which leads to a shift in the equilibrium distribution of species and leads to 
the slow disappearance of the fibrils. It is worth noting that, in this fibril dissolution 
experiment, both the initial and final fluorescence intensities depend on the lipid 
concentration, which can be attributed to a direct ThT-lipid interaction. 
Fluorescence polarisation measurements 
A stock solution of 2 mM DPH was prepared by solubilizing it in 100% EtOH 
overnight under stirring conditions at room temperature. The dye was then diluted 
into a stock solution of DMPS SUVs and the mixture was incubated at 45ºC for 30 
min; the final EtOH content of this mixture was kept below 0.5%. After incubation, 
the size of the SUVs was checked using dynamic light scattering (Malvern 
Instruments, Malvern, UK) and consisted of a distribution centred at a diameter of 23 
nm. The DMPS SUVs embedded with DPH were then incubated in the absence and 
the presence of -syn or 10% Triton X-100 and the different solutions were placed in 
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Corning 96 well plates with half-area (black/clear bottom polystyrene) non-binding 
surfaces. The fluorescence polarisation of DPH was then monitored using a plate 
reader (Polarstar Omega, BMG Labtech, Aylesbury, UK) under quiescent conditions 
at temperatures ranging from 10 to 60ºC. A 355 nm excitation filter and two matched 
emission filters (430 nm) were installed in the corresponding filter wheels. 
Aggregation kinetics 
Sample preparation and data acquisition 
-syn was incubated in 20 mM sodium phosphate, pH 6.5, in the presence of 50 M 
of ultrapure ThT and increasing concentrations of DMPS SUVs. The change in the 
ThT fluorescence signal with time was monitored using a plate reader (BMG Labtech, 
Aylesbury, UK) under quiescent conditions at 30ºC. Corning 96 well plates with half-
area (black/clear bottom polystyrene) non-binding surfaces, were used for each 
experiment. We also used polystyrene binding plates and obtained the same kinetics 
of amyloid formation by -syn in the presence of DMPS SUVs as those measured 
using non-binding plates. At the end of each aggregation experiment, the samples 
were ultracentrifuged at 90 krpm for 30 min and the concentration of the free 
monomer was calculated by measuring the UV spectrum of the supernatant and using 
the following expressions: 
[   ]  
      
        
  (9) 
[     ]        
       [   ]        
          
 (10) 
where Abs275 and Abs410 are the absorbance values measured at 275 and 410 nm, 
respectively,   , - , are the extinction coefficients of 
ThT at 275 and 410 nm and -syn at 275 nm, whose values were taken as 3, 200, 22, 
725 and 5, 600 M
-1
 cm
-1
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, respectively. The extinction coefficients of ThT at 275 nm 
and 410 nm were determined using a standard curve made by monitoring the 
absorbance spectra (250 - 600nm) of ThT samples whose concentration ranged from 0 
to 50 M. The concentration of the fibrils was then estimated using the following 
relationship: [     ]        [     ]        [     ]       , where [  
   ]        is the concentration of -syn at t = 0 in the well. 
Kinetic data analysis 
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The general approach to modelling the kinetics of fibrillar aggregation, as outlined 
previously 
28,29
, derives differential equations for the number P(t) and mass 
concentration M(t) of fibrils, which can then be solved to give the time evolution of 
the aggregation reaction. The processes usually taken into account are primary 
nucleation followed by elongation through addition of monomers to the fibril ends. In 
some systems secondary processes (i.e. formation of new growth-competent 
aggregates from existing aggregates, including fragmentation and heterogeneous 
nucleation on the surface of existing aggregates) are also relevant 
37
, but they were 
found to be negligible in the early time courses of the reactions studied in this work. 
In previous studies it has been shown that the elongation rate may saturate at high 
concentrations of monomeric -syn 36, which we take account of by treating 
elongation as a Michaelis-Menten like process 
55
. The resulting differential equation 
for the formation of fibril mass, M(t), is given by: 
  
  
   
    
  
    
  
     (11) 
where k+ is the elongation rate constant, m(t) is the free monomer concentration, P(t) 
is the number concentration of fibrils and KM is the Michaelis constant, which gives 
the monomer concentration at which saturation effects become important
55
. We then 
consider two different possible nucleation mechanisms, to obtain the equations for the 
variation in fibril numbers: 
Single-step nucleation: 
The simplest model is a nucleated growth model 
46
. As the present system involves 
nucleation only at the surface of vesicles (heterogeneous primary nucleation), we 
assume that the rate of heterogeneous primary nucleation also depends on the 
concentration, ”b”, of bound -syn. The corresponding differential equation is given 
by: 
  
  
        
  (12) 
where kn is the heterogeneous primary nucleation rate constant and n is the reaction 
order of the heterogeneous primary nucleation reaction relative to the free monomer, 
m(t). Note that for systems with a constant concentration of bound -syn this process 
is equivalent to simple homogeneous nucleation in solution with an effective rate 
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constant of knb. It is clear that the concentration of ”active” bound -syn, i.e. bound 
-syn that is able to form nuclei, will decrease over the course of a reaction, as free 
monomer remains at the plateau phase of the reaction and therefore heterogeneous 
nucleation processes must have ceased to produce new growth-competent nuclei. In 
the present study, we focus on the early time points in the overall reaction, when this 
effect is unlikely to play any significant role. In the early time limit, we can set 
         , which is equivalent to assuming that the depletion of monomer is 
insignificant for early times. Equations 11 and 12 can easily be solved and yield for 
the case of an unseeded reaction: 
     
        
       
 
          
 (13) 
Note the characteristic t
2
 dependence that arises from this expression. 
Two-step nucleation: 
At the next stage of complexity we introduce one conversion step into the 
heterogeneous primary nucleation process: the first step of the productive nucleation 
process is the formation a pre-nucleus, A, which then rearranges with rate constant kb 
to form a growth competent nucleus. The relevant equations are: 
  
  
        
         (14) 
  
  
        (15) 
As before, the solutions for the early time limit can easily be derived, yielding: 
     
        
    
  
 (       )
    ( 
      )  
    
   
 
        (16) 
Expansion of the exponential for the short time gives a t
3
 leading term (Eq. 17), 
predicting a sharper increase in aggregate concentration in the two-step nucleation 
mechanism than that predicted in the single-step nucleation mechanism. 
     
        
         
 
 (       )
 (17) 
We note that in the regime where we observe stimulation of -syn aggregation by 
SUVs, the local concentration of the protein at the surface of the vesicles is essentially 
constant. In fact, a change in lipid concentration leads only to a change in the total 
macroscopic concentration of bound protein, and not to a change in the local 
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concentration of the protein at the surface of each vesicle. Therefore, the reaction 
order of the nucleation step with respect to bound protein is not accessible through 
our current experimental strategy. An increase in lipid concentration will indeed lead 
to a proportional increase in nucleation rate, simply due to the fact that there is a 
larger lipid surface for the nucleation to take place on. 
Fitting of the kinetic data 
The above early time solutions (Eqs. 13 and 16) were used to fit globally the first 30 h 
of the kinetic traces at all the monomer and lipid concentrations shown in Fig. 6 and 
Supplementary Fig. 4. The fits were performed using the Knowles group online 
aggregation fitter (http://www.amylofit.ch.cam.ac.uk/), which is based on a basin-
hopping algorithm 
56
. The residuals are the difference between the fitted curves and 
the experimental values (average this over the repeats), at each data point 
(Supplementary Fig. 5). The mean squared error of the fits (as indicated in the legends 
of Supplementary Fig. 5) is the sum of all squared residuals over the number of data 
points minus the number of free parameters i.e.  
           
∑           
  
 
    
 (18) 
where N is the number of data points and Np is the number of free parameters. 
Comparison of the rate of formation of new nuclei via primary nucleation of -
syn under quiescent conditions in the presence and absence of SUVs 
Quiescent conditions in the absence of SUVs 
In order to compare the rate of formation of new nuclei via primary nucleation of -
syn under quiescent conditions in the presence and absence of SUVs, we first 
estimated the upper bound of this rate in the absence of SUVs. We have recently 
shown that under quiescent conditions and in the absence of SUVs, the rate of 
secondary nucleation is negligible at pH values above 6 
36
. Our data shows in fact that 
in the absence of SUVs, no fibrils are detected when 140 M -syn is incubated 
under quiescent conditions during 125h (Supplementary Fig. 6) suggesting that the 
rate of primary nucleation under such conditions is much lower than in the presence 
of SUVs. Despite the lack of observed aggregation, we can define an upper bound for 
the rate of primary nucleation in the absence of SUVs, by assuming that under these 
conditions the mechanism of aggregation of -syn consists of a nucleation step 
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followed by elongation and that the total mass of fibrils varies with time according to 
46
: 
         [        √
 
 
    
 
 ] (19) 
with   √          . The lowest ThT signal that we measured corresponds to the 
formation of 4 M fibrils and is 10  higher than the signal of the background 
(Supplementary Fig. 6). We can thus assume that the minimum concentration of 
fibrils that we can detect using our experimental set up is approximately 0.4 M, 
therefore putting an upper bound on the concentration of fibrils formed after 125h. 
We thus estimated the upper limit of the rate of formation of new nuclei via primary 
nucleation (knm(0)n) of -syn under quiescent conditions using Eq. 19 and the 
following values for the different constants: M(t) ~ 0.4 M, k+ = 2 • 10
3
 s
-1
, n = 2 and 
m(0) = 140 M and obtained a value of 7 • 10-18 M s-1. It is worth mentioning, that 
any contribution from secondary processes, which have been assumed to be negligible 
in the above equation, would render this value even smaller. 
Quiescent conditions in the presence of SUVs 
The global analysis of our data sets have shown that in the presence of SUVs, knk+ = 
1.2 • 10-5 M-(n+1) s-2. For an initial concentrations of -syn free and -syn bound to the 
SUVs of 140 M and 10 M, respectively, we can estimate the rate of formation of 
new nuclei via primary nucleation (knbm(0)
n
) to 1 • 10-14 M s-1. Under these 
conditions, the presence of SUVs thus enhanced the rate of formation of new nuclei 
via primary nucleation of -syn by a factor of 103. 
Atomic Force Microscopy 
Data Acquisition 
For atomic force microscopy (AFM) imaging, samples were diluted to ~1 M total 
protein concentration into dH2O, and 10 l were pipetted onto freshly cleaved mica 
(Agar Scientific, Stansted, UK) and left to dry. 
The samples were imaged with a Nanowizard II atomic force microscope (JPK 
Instruments, Waterbeach, UK) in intermittent contact mode in air, using NSC 36 
cantilevers (Mikromasch, Tallinn, Estonia) with resonant frequencies between 70 and 
150 kHz. 
 23 
Length distribution analysis 
In order to evaluate the number of nucleation sites per vesicle, we estimated the 
number of fibrils and SUVs in solution by analysing AFM images of the sample taken 
at the end of the reaction of amyloid formation, when 200 M -syn were incubated 
in the presence of 600 M DMPS and led to the conversion of 40 M -syn into 
fibrils (Fig. 5a, main manuscript). First, we estimated the concentration of vesicles in 
solution formed by 600 M DMPS. We have previously shown (see section” 
Estimation of the local concentration of -syn at the surface of a SUV”) that there are 
6,000 DMPS lipids per SUVs; we thus estimated the concentration of SUVs in 
solution to 0.1 M ([    ]  
                                
                                 
). 
Second, the concentration of fibrils in solution was calculated as follows. We 
estimated the average length of -syn fibrils by measuring the length distribution of 
the fibrils on the AFM image (Fig. 5a, main manuscript). The average length of the 
fibril formed was estimated to be 375 nm which corresponds to ~ 400 monomers per 
fibril (
       
     
 
      
 
, with width = 5 nm,  = 1.35 g.cm-3 57, NA, the number of 
Avogadro and M, the molecular mass of -syn). The concentration of fibrils can then 
be estimated to 0.1 M ([       ]  
[            ]
                           
, [-synfibrils] = 40 M), 
which corresponds to the concentration of SUVs in solution, suggesting that there is 
of the order of one nucleation event per SUV on average. 
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